Lan Ly, PhD., Viral Gene Therapy Business Steering Group Lead and Sara Miller, Cell Therapy Business Steering Group Lead at FUJIFILM Diosynth Biotechnologies share how FDB is poised to facilitate the development and manufacture of your novel advanced therapy.

Lan Ly provides an overview of FDB’s Viral Gene Therapy capacity and capabilities, which include exosomes, gene therapies, oncolytic viruses, and vaccines across the CDMO’s global locations in the United States and Europe. Sara Miller dives into FDB’s Cell Therapy capabilities and capacity at their dedicated Cell Therapy site in Thousand Oaks, California, including autologous and allogeneic cell therapy.

CDMO capacity webinar

View the webinar